Suppression of type 2 NO-synthase activity in macrophages by Candida albicans.

Schröppel, K; Kryk, M; Herrmann, M; Leberer, E; Röllinghoff, M; Bogdan, C

Schröppel, K; Kryk, M; Herrmann, M; Leberer, E; Röllinghoff, M; Bogdan, C.

Affiliation

Schröppel K; Institute of Clinical Microbiology, Immunology and Hygiene, University of Erlangen, Germany. klaus.schroeppel@mikrobio.med.uni-erlangen.de

Int J Med Microbiol ; 290(8): 659-68, 2001 Mar.

Article in En | MEDLINE | ID: mdl-11310444

Subject(s)

Candida albicans/pathogenicity; Macrophages, Peritoneal/microbiology; Nitric Oxide Synthase/antagonists & inhibitors; Animals; Apoptosis; Candida albicans/growth & development; Cells, Cultured; Interferon-gamma/pharmacology; Lipopolysaccharides/pharmacology; Macrophage Activation/drug effects; Macrophages, Peritoneal/enzymology; Mice; Nitric Oxide/metabolism; Nitric Oxide Synthase/metabolism; Nitric Oxide Synthase Type II

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Candida albicans / Macrophages, Peritoneal / Nitric Oxide Synthase Limits: Animals Language: En Journal: Int J Med Microbiol Journal subject: MICROBIOLOGIA Year: 2001 Document type: Article Affiliation country: Germany Country of publication: Germany

Search on Google

Add to My VHL

XML

PubMed Links